AMG 732 / Amgen - LARVOL DELTA

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease (clinicaltrials.gov) - P1 | N=88 | Recruiting | Sponsor: Amgen | Active, not recruiting ➔ Recruiting | N=48 ➔ 88

Enrollment change • Enrollment open • Ophthalmology • Thyroid Eye Disease

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease (clinicaltrials.gov) - P1 | N=48 | Active, not recruiting | Sponsor: Amgen | Recruiting ➔ Active, not recruiting

Enrollment closed • Ophthalmology • Thyroid Eye Disease

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease (clinicaltrials.gov) - P1 | N=48 | Recruiting | Sponsor: Amgen | Trial primary completion date: Jun 2027 ➔ Feb 2027

Trial primary completion date • Ophthalmology • Thyroid Eye Disease

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease (clinicaltrials.gov) - P1 | N=40 | Recruiting | Sponsor: Amgen | Not yet recruiting ➔ Recruiting

Enrollment open • Ophthalmology • Thyroid Eye Disease

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease (clinicaltrials.gov) - P1 | N=40 | Not yet recruiting | Sponsor: Amgen

New P1 trial • Ophthalmology • Thyroid Eye Disease